S100A7 expression levels in coordination with interleukin-8 indicate the clinical response to infliximab for psoriasis patients.

Sato, Yasuhiko; Kajihara, Ikko; Yamada-Kanazawa, Saori; Jinnin, Masatoshi; Ihn, Hironobu

Sato, Yasuhiko; Kajihara, Ikko; Yamada-Kanazawa, Saori; Jinnin, Masatoshi; Ihn, Hironobu.

Affiliation

Sato Y; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kajihara I; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yamada-Kanazawa S; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Jinnin M; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Ihn H; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

J Dermatol ; 44(7): 838-839, 2017 Jul.

Article de En | MEDLINE | ID: mdl-28677139

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psoriasis / Interleukine-8 / Produits dermatologiques / Infliximab / Protéine S100 de type A7 liant le calcium Type d'étude: Observational_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: J Dermatol Année: 2017 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google